816463-40-8 Usage
Description
Tert-butyl (1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-yl)carbamate is a complex chemical compound that features a combination of quinoline, piperidine, benzoimidazole, and carbamate functional groups. It is a tert-butyl carbamate ester derivative, with a quinoline moiety connected to a piperidine ring, which is further linked to a benzoimidazole group. Additionally, it includes a 3-methyloxetan-3-yl)methoxy moiety. The presence of these multiple functional groups suggests that this compound may exhibit a range of biological activities, making it a candidate for pharmaceutical development, research reagents, or chemical synthesis. Further research and analysis are required to explore and exploit the full potential of this intricate molecule.
Uses
Used in Pharmaceutical Development:
Tert-butyl (1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-yl)carbamate is used as a pharmaceutical agent due to its complex structure and the potential for diverse biological activities. tert-butyl (1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-yl)carbamate's multiple functional groups may contribute to its interaction with various biological targets, offering opportunities for the treatment of different diseases and conditions.
Used in Research Reagents:
In the field of scientific research, tert-butyl (1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-yl)carbamate serves as a valuable reagent. Its unique structure allows researchers to study its interactions with biological systems, potentially leading to new insights into molecular mechanisms and the discovery of novel therapeutic approaches.
Used in Chemical Synthesis:
Tert-butyl (1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-yl)carbamate is utilized in chemical synthesis processes, where its complex structure and functional groups can be employed to create new compounds with specific properties. This can be particularly useful in the development of advanced materials, catalysts, or other specialty chemicals.
Used in Drug Discovery:
In the drug discovery industry, tert-butyl (1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-yl)carbamate is used as a starting material or intermediate in the synthesis of new drug candidates. Its structural complexity and the presence of multiple functional groups make it a promising candidate for the development of innovative therapeutic agents.
Used in Medicinal Chemistry:
Tert-butyl (1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-yl)carbamate is applied in medicinal chemistry for the design and optimization of new drugs. Its unique structural features can be leveraged to improve the potency, selectivity, and pharmacokinetic properties of drug molecules, leading to more effective treatments for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 816463-40-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,1,6,4,6 and 3 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 816463-40:
(8*8)+(7*1)+(6*6)+(5*4)+(4*6)+(3*3)+(2*4)+(1*0)=168
168 % 10 = 8
So 816463-40-8 is a valid CAS Registry Number.
816463-40-8Relevant articles and documents
Preparation method of anticancer drug
-
, (2019/05/08)
The invention relates to a preparation method of an anticancer drug. The anticancer drug is Crenolanib. The preparation method comprises the following steps: taking 2-chlo-8-hydroxyquinoline as a rawmaterial, reacting with trifluoromethanesulfonyl chloride, condensing, dehydrating, performing dehydrochlorination, and performing deprotection to obtain the anticancer drug. Compared with an existingCrenolanib production technology, the preparation method has the characteristics that processes are simple and easy, the purity is high, the yield is high, the processes are short, materials are easyto obtain and low in price, the cost is low, the operation is safe and the like; the industrial production can be conveniently carried out; and technical foundation is supplied for massive productionof the drug and structure-like drugs.
Synthesis method of drug for treating leukemia
-
, (2018/03/01)
The invention relates to a synthesis method of a drug for treating leukemia. The synthesis method comprises that 1, a compound 3-methyl-3-oxetanemethanol and sodium metal undergo a reaction to produce 3-sodium methoxide-3-methyl-3-oxetane, 2, 4-amino-3-nitrochlorobenzene is added into the product obtained by the step 1 so that reddish-orange solids (A1) are obtained, a compound 8-benzyloxyquinolin-2-chlorine and A1 undergo a reaction to produce orange solids A2, 3, the compounds A2, 13g of palladium/carbon and formic acid undergo a reaction, formamidine acetate is added into the reaction product, and the mixture is subjected to reflux and drying so that white-like (or yellow) solids A3 are obtained, and 4, the compounds A3 and benzenesulfonyl chloride undergo a reaction, the product is dried to form maize-yellow solids A4, BINAP, A4, tert-butyl piperidin-4-yl-carbamate and potassium carbonate undergo a reaction, the reaction product is dried to form A5, and the A5 is refined through the step 5 so that a pure product is obtained. In the steps 1 and 2, a one-pot method is used.
